Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
NURIX THERAPEUTICS, INC. (NRIX), most recent 12 months reported: revenue $701.94M, net income $294.88M, free cash flow $369.81M. Latest balance sheet on file: liquid cash $592.94M. From SEC filings. More on NURIX THERAPEUTICS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: PACIRA BIOSCIENCES, INC. · Amphastar Pharmaceuticals, Inc. · ULTRAGENYX PHARMACEUTICAL INC. · BridgeBio Pharma, Inc. · ARROWHEAD PHARMACEUTICALS, INC. · Mirum Pharmaceuticals, Inc. · TRAVERE THERAPEUTICS, INC. · OPKO Health, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.